Dr Reddy’s recalls 2,980 bottles of Atorvastatin Calcium tablets

The US-based unit of the company initiated the nationwide recall on February 19, 2021, and the USFDA has categorised it as a Class III recall.

52
Recall
Picture: Pixabay

Dr Reddy’s Laboratories is recalling 2,980 bottles of Atorvastatin Calcium tablets in the US due to quality issues. Atorvastatin is indicated to lower cholesterol in the blood for adults and children over ten years of age.

The drug is also prescribed to lower the risk of heart attack and stroke in patients with cardiovascular diseases, diabetes, and other risk factors such as eye problems, kidney diseases, or high blood pressure.

As per the US Food and Drug Administration’s (USFDA) latest Enforcement report, the Hyderabad-based drug major is voluntarily recalling the affected lots of the drug in 10 mg strength due to “failed impurities degradation specifications”.

Medicine Tablet
Picture: Pixabay

The 500-count 2,980 bottles have been produced at Dr Reddy’s Bachupally (Telangana) plant and later shipped to its US arm which is now in the process of recalling the lot.

The New Jersey-based, Dr Reddy’s Laboratories initiated the nationwide recall on May 4 and the USFDA has categorised it as a Class III recall which is initiated in a “situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences”.

In March this year, USFDA had stated that Dr Reddy’s is recalling 10,440 (90-count) and 2,24,710 (500 count) bottles of Atorvastatin Calcium tablets in the US market.

The US-based unit of the company initiated the nationwide recall on February 19, 2021, and the USFDA has categorised it as a Class III recall.

The drug firm had also recalled 16,449 bottles of Progesterone Capsules (200 mg), used to cause menstrual periods in women who have not yet reached menopause, in the US market for “failed dissolution specifications”.

Sun Pharma recalls 50,868 bottles of diabetes drug in US

Lupin, Sun, Jubilant recall generic medicines in US

Sun Pharma, Alembic recall products in the US market

Zydus Cadila, Alembic Pharma recall these 2 drugs in US

Pharma Companies recall these drugs in US

Lupin, Aurobindo units recall medicines in US market

Schedules – Drugs and Cosmetics Act 1940 and Rules 1945

Overcharging: Haryana plans surgical strike on Hospitals

Serum gets nod from DCGI to produce Sputnik V vaccine in…

Recovered C-19 patients must take this medicine for 2-3 months

Dos and don’ts of CT scanning in C-19

Glenmark gets USFDA nod for Theophylline ER tablets

Subscribe for daily free updates on Telegram

Follow us on Facebook and Linkedin

For daily free updates on WhatsApp, click here

Enter your email address:

Delivered by FeedBurner